Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/53150
Conference/Presentation Title: | Correlation between PI-RADS score and prostate core biopsy histopathology. | Authors: | Sin J.;Rorke S. | Monash Health Department(s): | Pathology | Institution: | (Sin) Faculty of Medicine, Nursing and Health Sciences, Monash University, VIC, Australia (Sin, Rorke) Department of Anatomical Pathology, Monash Health, VIC, Australia |
Presentation/Conference Date: | 23-Jan-2025 | Copyright year: | 2025 | Publisher: | Elsevier B.V. | Publication information: | Pathology. Conference: Pathology Update 2025. Melbourne Convention and Exhibition Centre, Melbourne Australia. 57(Supplement 1) (pp S66-S67), 2025. Date of Publication: 01 Feb 2025. | Journal: | Pathology | Abstract: | Background: Traditionally, prostate cancer (PCa) diagnosis relies on invasive biopsies. The introduction of the Prostate Imaging-Reporting and Data System (PI-RADS) has improved MRI interpretation, assisting with the detection and risk stratification of clinically-significant prostate cancer (csPCa).1,2 Aims: This project aims to investigate the role and correlation between PI-RADS and prostate core biopsy histopathology in staging csPCa at a large tertiary hospital. Method(s): We conducted a retrospective analysis of 106 patients at Monash Health who underwent MRI and subsequent prostate core biopsy between 1 January 2022 and 31 December 2022. The following characteristics were included: maximum PI-RADS score for each patient and ISUP grade groups of histopathology. Result(s): Of the 106 biopsies, 94% were PI-RADS 3,4 and 5 lesions, which had mean ISUP grades of 1.87, 1.73 and 7.75 respectively. Using Spearman's rank correlation coefficient, the rho coefficient was 0.3564 (p-value = 0.00018), demonstrating a strong correlation between ISUP grades and PI-RADS scores. Discussion(s): This study supports the role of PI-RADS as a triage tool for accurate detection and risk stratification of suspected csPCa. The statistically significant positive relationship between ISUP and PI-RADS scores reinforces the accuracy of MRI in diagnosing PCa and expediting treatment. References 1. Lomas DJ, Ahmed HU. All change in the prostate cancer diagnostic pathway. Nat Rev Clin Oncol 2020; 17: 372-81. 2. Gupta R, Mahajan M, Sharma P. Correlation between prostate imaging reporting and Data System Version 2, Prostate-Specific Antigen Levels, and local staging in biopsy-proven carcinoma prostate: a retrospective study. Int J Appl Basic Med Res 2021; 11: 32-5.Copyright © 2024 | Conference Name: | PATHOLOGY UPDATE 2025 | Conference Start Date: | 2025-02-21 | Conference End Date: | 2025-02-23 | Conference Location: | Melbourne Convention and Exhibition Centre, Melbourne, Australia | DOI: | http://monash.idm.oclc.org/login?url=http://acs.hcn.com.au/?acc=36265&url=https://dx.doi.org/10.1016/j.pathol.2024.12.271 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/53150 | Type: | Conference Abstract | Subjects: | histopathology MRI scanner nuclear magnetic resonance imaging prostate cancer |
Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.